A High-Content Screening Approach to Identify MicroRNAs Against Head and Neck Cancer Cell Survival and EMT in an

Bruno Sangiorgi1,2, Felipe Canto de Souza1,2, Ildercílio Mota de Souza Lima1,2

  • 1Center for Cell-Based Therapy (CTC), Regional Blood Center of Ribeirão Preto, Ribeirão Preto, Brazil.

Frontiers in Oncology
|December 3, 2019
PubMed
Summary

This study identifies microRNAs (miRs) that inhibit head and neck squamous cell carcinoma (HNSCC) cell survival and metastasis in an inflammatory environment. Targeting NF-κB, PI3K/AKT, and Wnt/beta-catenin pathways shows promise for HNSCC therapies.

Related Concept Videos